Promotions & Moves
Related Searches:
Filter by:
361 - 375 of 1168 results
May 20, 2011
Mark Reisenauer has been appointed vice president of sales and marketing, oncology, at Astellas Pharma US, Inc.
Read More »
May 20, 2011
Fereydoun Firouz has resigned from his position as president and chief executive officer of EMD Serono, Inc., an affiliate of Merck KGaA.
Read More »
May 17, 2011
Michael Zhou, Ph.D. has been appointed senior director of research and development at Bioanalytical Systems Inc. (BASi).
Read More »
May 16, 2011
Mary G. Foster, PharmD has been appointed corporate vice president of Quality and Regulatory Affairs at Aphena Pharma Solutions, effective June 1st.
Read More »
May 12, 2011
Harry Jeffreys has been appointed vice president of Quality Management Systems and Compliance at Catalent Pharma Solutions.
Read More »
May 12, 2011
Dr. Dorla Mirejovsky has been appointed senior director of Formulation Development at Irvine Pharmaceutical Services.
Read More »
May 11, 2011
Michael E. Lytton has been appointed Patheon’s executive vice president of Corporate Development and Strategy and general counsel.
Read More »
May 6, 2011
Mark Dean-Netscher has been appointed chief operating officer of Penn Pharma, effective May 16th.
Read More »
May 6, 2011
Todd Kole has been named vice president of Clinical Project Services (CPS) and a member of the Executive Leadership Team at Almac Clinical Technologies.
Read More »
May 5, 2011
Claes Glassell has been appointed chief executive officer of CMC Biologics.
Read More »
May 4, 2011
Pfizer, Wyeth vet to take role over R&D and technology programs
Read More »
May 4, 2011
Jeffrey S. Litwin, M.D. has been appointed president and chief executive officer of ERT and a member of the board.
Read More »
May 2, 2011
Richard C. (Rick) Proehl bas been appointed vice president of manufacturing at Cambridge Major Laboratories.
Read More »
361 - 375 of 1168 results
